[1] 李小毅, 张波, 林岩松.  成人甲状腺结节与分化型甲状腺癌诊治指南(2015年美国甲状腺协会)解读[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(4): 309-315.   doi: 10.3760/cma.j.issn.1673-0860.2017.04.018
Li XY, Zhang B, Lin YS.  The interpretation of 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J]. Chin J Otorhinolaryngol Head Neck Surg, 2017, 52(4): 309-315.   doi: 10.3760/cma.j.issn.1673-0860.2017.04.018
[2] Gamme G, Parrington T, Wiebe E, et al.  The utility of thyroid ultrasonography in the management of thyroid nodules[J]. Can J Surg, 2017, 60(2): 134-139.   doi: 10.1503/cjs.010316
[3] Chen WQ, Zheng RS, Baade PD, et al.  Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.   doi: 10.3322/caac.21338
[4] Haugen BR, Alexander EK, Bible KC, et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133.   doi: 10.1089/thy.2015.0020
[5] Amin MB, Greene FL, Edge SB, et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93-99.   doi: 10.3322/caac.21388
[6] Tessler FN, Middleton WD, Grant EG, et al.  ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee[J]. J Am Coll Radiol, 2017, 14(5): 587-595.   doi: 10.1016/j.jacr.2017.01.046
[7] Lim H, Devesa SS, Sosa JA, et al.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013[J]. JAMA, 2017, 317(13): 1338-1348.   doi: 10.1001/jama.2017.2719
[8] Pellegriti G, Frasca F, Regalbuto C, et al.  Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors[J]. J Cancer Epidemiol, 2013, 2013: 965212-.   doi: 10.1155/2013/965212
[9] 丁颖, 李文亮, 李强, 等.  分化型甲状腺癌术后首次血清刺激性Tg水平对远处转移的预测价值[J]. 国际放射医学核医学杂志, 2019, 43(4): 308-313.   doi: 10.3760/cma.j.issn.1673-4114.2019.04.003
Ding Y, Li WL, Li Q, et al.  Predictive value of postoperative initial stimulated thyroglobulin level on distant metastasis of differentiated thyroid carcinoma[J]. Int J Radiat Med Nucl Med, 2019, 43(4): 308-313.   doi: 10.3760/cma.j.issn.1673-4114.2019.04.003
[10] Kitahara CM, Sosa JA.  The changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2016, 12(11): 646-653.   doi: 10.1038/nrendo.2016.110
[11] 周衍, 田俊, 肖景榕.  乳头状甲状腺癌患病影响因素病例对照研究[J]. 中国公共卫生, 2016, 32(11): 1535-1539.   doi: 10.11847/zgggws2016-32-11-23
Zhou Y, Tian J, Xiao JR.  Influencing factors of papillary thyroid carcinoma: a case-control study[J]. Chin J Public Health, 2016, 32(11): 1535-1539.   doi: 10.11847/zgggws2016-32-11-23
[12] Bhaskaran K, Douglas I, Forbes H, et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults[J]. Lancet, 2014, 384(9945): 755-765.   doi: 10.1016/S0140-6736(14)60892-8
[13] Neves JS, Castro Oliveira S, Souteiro P, et al.  Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function[J]. Obes Surg, 2018, 28(1): 97-103.   doi: 10.1007/s11695-017-2792-5
[14] Remonti LR, Kramer CK, Leitão CB, et al.  Thyroid Ultrasound Features and Risk of Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies[J]. Thyroid, 2015, 25(5): 538-550.   doi: 10.1089/thy.2014.0353
[15] 马春旭, 袁卫红, 赵艳花, 等.  99Tcm-MIBI显像联合超声鉴别诊断甲状腺结节良恶性的临床研究[J]. 中华核医学与分子影像杂志, 2016, 36(4): 326-329.   doi: 10.3760/cma.j.issn.2095-2848.2016.04.011
Ma CX, Yuan WH, Zhao YH, et al.  99Tcm-MIBI imaging combined with ultrasonography to identify benign and malignant thyroid nodules[J]. Chin J Nucl Med Mol Imaging, 2016, 36(4): 326-329.   doi: 10.3760/cma.j.issn.2095-2848.2016.04.011
[16] Davis PJ, Hercbergs A, Luidens MK, et al.  Recurrence of Differentiated Thyroid Carcinoma During Full TSH Suppression: Is the Tumor Now Thyroid Hormone Dependent?[J]. Horm Cancer, 2015, 6(1): 7-12.   doi: 10.1007/s12672-014-0204-z
[17] Fighera TM, Perez CLS, Faris N, et al.  TSH levels are associated with increased risk of thyroid carcinoma in patients with nodular disease[J]. Endokrynol Pol, 2015, 66(6): 480-485.   doi: 10.5603/EP.a2015.0059
[18]

Al Dawish MA, Robert AA, Thabet MA, et al. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy [J/OL]. Cancer Inform, 2018, 17: 1176935118765132[2019-12-25]. https://journals.sagepub.com/doi/10.1177/1176935118765132. DOI: 10.1177/1176935118765132.

[19] 闫慧娴, 谷伟军, 杨国庆, 等.  血清促甲状腺激素与甲状腺乳头状微小癌相关性研究[J]. 中华内分泌代谢杂志, 2014, 30(8): 669-672.   doi: 10.3760/cma.j.issn.1000-6699.2014.08.008
Yan HX, Gu WJ, Yang GQ, et al.  Association of serum thyrotropin level with papillary thyroid microcarcinoma[J]. Chin J Endocrinol Metab, 2014, 30(8): 669-672.   doi: 10.3760/cma.j.issn.1000-6699.2014.08.008
[20] 郑晓, 文祯, 姜涛, 等.  甲状腺乳头状癌风险评估量表的建立及与甲状腺细针穿刺细胞学检查的诊断效能比较[J]. 中华内分泌代谢杂志, 2017, 33(9): 755-759.   doi: 10.3760/cma.j.issn.1000-6699.2017.09.010
Zheng X, Wen Z, Jiang T, et al.  Establishment of risk score for papillary thyroid carcinoma and comparison of diagnostic efficacy with thyroid fine needle aspiration cytodiagnosis[J]. Chin J Endocrinol Metab, 2017, 33(9): 755-759.   doi: 10.3760/cma.j.issn.1000-6699.2017.09.010
[21] 贾晓蒙, 庞萍, 宋烨琼, 等.  体重指数与甲状腺乳头状癌患病风险的相关性研究[J]. 中华内分泌代谢杂志, 2017, 33(4): 296-300.   doi: 10.3760/cma.j.issn.1000-6699.2017.04.005
Jia XM, Pang P, Song YQ, et al.  Association of body mass index and the risk of papillary thyroid carcinoma[J]. Chin J Endocrinol Metab, 2017, 33(4): 296-300.   doi: 10.3760/cma.j.issn.1000-6699.2017.04.005
[22] Hegedus L.  Clinical Practice: The Thyroid Nodule[J]. N Engl J Med, 2004, 351(17): 1764-1771.   doi: 10.1056/NEJMcp031436
[23] Trimboli P, Treglia G, Guidobaldi L, et al.  Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis[J]. Endocrine, 2014, 46(1): 52-59.   doi: 10.1007/s12020-013-0057-1
[24] 陈静, 汤雅迪, 周迎生.  超声测量下的甲状腺结节直径与甲状腺乳头状癌的相关性[J]. 中华医学杂志, 2018, 98(44): 3575-3578.   doi: 10.3760/cma.j.issn.0376-2491.2018.44.005
Chen J, Tang YD, Zhou YS.  Association between thyroid nodule diameter measured by ultrasound and thyroid papillocarcinoma[J]. Natl Med J China, 2018, 98(44): 3575-3578.   doi: 10.3760/cma.j.issn.0376-2491.2018.44.005
[25]

郝丽君, 方军初, 洪智慧, 等. 99mTcO4-核素显像联合超声检查对甲状腺结节的鉴别诊断价值[J]. 中华医学杂志, 2011, 91(45): 3210−3213. DOI: 10.3760/cma.j.issn.0376-2491.2011.45.012.

Hao LJ, Fang JC, Hong ZH, et al. Values Of 99mTcO4- thyroid imaging plus ultrasonography in the differential diagnoses of thyroid nodules[J]. Natl Med J China, 2011, 91(45): 3210−3213. DOI: 10.3760/cma.j.issn.0376-2491.2011.45.012.

[26] 吕秀芳, 王延海, 孙丹立, 等.  甲状腺良恶性结节的超声特征及血流情况分析[J]. 临床超声医学杂志, 2019, 21(6): 435-438.   doi: 10.3969/j.issn.1008-6978.2019.06.011
Lyu XF, Wang YH, Sun DL, et al.  Ultrasonic characteristics and blood flow analysis of benign and malignant thyroid nodules[J]. J Clin Ultrasound in Med, 2019, 21(6): 435-438.   doi: 10.3969/j.issn.1008-6978.2019.06.011
[27] Valderrabano P, Khazai L, Thompson ZJ, et al.  Association of Tumor Size with Histologic and Clinical Outcomes Among Patients with Cytologically Indeterminate Thyroid Nodules[J]. JAMA Otolaryngol Head Neck Surg, 2018, 144(9): 788-795.   doi: 10.1001/jamaoto.2018.1070
[28]

Ancker OV, Wehland M, Bauer J, et al. The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors[J/OL]. Int J Mol Sci, 2017, 18(3): 625[2019-12-25]. https://www.mdpi.com/1422-0067/18/3/625. DOI: 10.3390/ijms18030625.

[29] 庞丽娜, 秦伟栋, 韩景锐, 等.  二维灰阶超声联合超声造影对甲状腺TI-RADS 3-5类结节鉴别诊断的价值[J]. 中华超声影像学杂志, 2019, 28(2): 123-126.   doi: 10.3760/cma.j.issn.1004-4477.2019.02.007
Pang LN, Qin WD, Han JR, et al.  Value of conventional ultrasound combined with contrast-enhanced ultrasound in differential diagnosis of thyroid TI-RADS 3-5 nodules[J]. Chin J Ultrasonogr, 2019, 28(2): 123-126.   doi: 10.3760/cma.j.issn.1004-4477.2019.02.007